Can I Take St. John's Wort with Armour Thyroid?

The Short Answer: These Two Do Not Mix Well

Combining St. John's Wort (Hypericum perforatum) with Armour Thyroid is not straightforwardly safe. The supplement does not block thyroid hormones directly, but it speeds up the liver enzymes and transport proteins that clear them from your body. The result is that the same Armour Thyroid dose may deliver less active hormone to your tissues, your TSH can creep upward, and hypothyroid symptoms can return even though you haven't changed your prescription.

This matters more for women than many clinicians realize. Hypothyroidism affects women at roughly five to eight times the rate seen in men, and the conditions that push women toward St. John's Wort, including perimenopausal mood changes and mild-to-moderate depression, tend to coincide with the same life decades when thyroid disease is most likely to emerge or worsen.

What Armour Thyroid Actually Is

Armour Thyroid is a prescription natural desiccated thyroid (NDT) product derived from porcine thyroid glands. Unlike levothyroxine, which contains only synthetic T4, Armour Thyroid supplies both thyroxine (T4) and triiodothyronine (T3) in an approximately 4:1 ratio. That T3 component is pharmacologically significant because T3 is three to four times more potent than T4 at the thyroid hormone receptor and has a shorter half-life of roughly one day, compared with seven days for T4.

Why the T3 Component Changes the Interaction Picture

Because T3 is cleared faster and relies on both hepatic metabolism and active intestinal transport, anything that accelerates those pathways will affect the T3 fraction of Armour Thyroid more acutely than it would affect a pure T4 product. Women on Armour Thyroid for its T3 content may therefore experience a relatively faster return of hypothyroid symptoms when an enzyme inducer like St. John's Wort is added.

Who Uses Armour Thyroid

Women choose Armour Thyroid over levothyroxine for several reasons: persistent fatigue or brain fog despite a "normal" TSH on T4 monotherapy, personal preference for a less synthetic product, or a clinician's recommendation based on conversion issues. A 2019 survey of thyroid patients published in Thyroid found that 48.6% of those who had tried both NDT and levothyroxine preferred NDT. That preference is more common in women, who make up the vast majority of hypothyroid patients.

What St. John's Wort Does in Your Body

St. John's Wort is used most often for mild-to-moderate depression, perimenopause-related mood symptoms, and sleep disturbance. The active constituents most studied for its antidepressant effect are hypericin and hyperforin. Hyperforin in particular is a potent activator of the pregnane X receptor (PXR), a nuclear receptor that upregulates the transcription of CYP3A4, CYP2C9, and the efflux transporter P-glycoprotein.

The CYP3A4 and P-Glycoprotein Problem

CYP3A4 is responsible for oxidative metabolism of a wide range of drugs, and P-glycoprotein limits intestinal absorption by pumping compounds back into the gut lumen. When St. John's Wort upregulates both, the consequences for co-administered drugs can include reduced peak plasma concentration, reduced area under the curve (AUC), and shortened effective duration. The FDA has issued warnings about St. John's Wort interactions with drugs as diverse as cyclosporine, antiretrovirals, oral contraceptives, and warfarin for exactly this reason.

Does St. John's Wort Directly Affect the Thyroid?

This is where the evidence is thin, and you deserve a straight answer about that gap. There is no well-powered randomized controlled trial in humans that specifically measures the effect of St. John's Wort on TSH or free T4 levels in people taking thyroid hormone replacement. What exists is mechanistic data on CYP3A4 induction, case reports, and the known pharmacokinetics of T3 and T4. Animal studies have suggested that hypericin can affect thyroid axis signaling, but this has not been confirmed at clinical doses in women. The interaction concern is therefore largely pharmacokinetic and inferred, not directly proven in a thyroid-specific human trial. That gap matters. It means the risk is real but the magnitude is uncertain.

How the Interaction Unfolds Clinically

When you start St. John's Wort while already taking Armour Thyroid, the sequence typically looks like this:

1. Hyperforin activates PXR within days of regular dosing.
2. CYP3A4 and P-glycoprotein expression in the liver and intestinal wall increases over one to two weeks.
3. Thyroid hormone clearance accelerates and intestinal absorption of T4 and T3 decreases modestly.
4. Free T4 and free T3 levels drop.
5. The pituitary senses lower circulating thyroid hormone and begins secreting more TSH.
6. TSH rises, sometimes into the hypothyroid range, typically within two to four weeks of consistent St. John's Wort use.

You might notice fatigue returning, cold intolerance, constipation, slower thinking, or heavier periods. Or you might feel nothing obvious until a lab draw catches a rising TSH.

What Happens If You Stop St. John's Wort

Enzyme induction reverses, but not immediately. CYP3A4 induction from St. John's Wort generally resolves within one to two weeks after discontinuation. If your Armour Thyroid dose was increased during the period of co-use to compensate for the interaction, stopping St. John's Wort without adjusting that dose downward could leave you over-replaced, with palpitations, heat intolerance, and a suppressed TSH. Any change in St. John's Wort use requires a follow-up TSH check four to six weeks later.

Women-Specific Risks of Undertreated Hypothyroidism

This is not an abstract pharmacology question. The downstream effects of a rising TSH hit women at specific, consequential moments across the lifespan.

Reproductive Years and Fertility

Subclinical hypothyroidism, defined as a TSH above 2.5 mIU/L with normal free T4, is associated with anovulatory cycles, luteal phase defects, and a roughly twofold increase in early pregnancy loss. If St. John's Wort is quietly pushing your TSH upward while you are trying to conceive, you may attribute difficulty getting or staying pregnant to other causes without realizing your thyroid is drifting out of range.

PCOS

Thyroid dysfunction is more prevalent in women with PCOS than in the general female population. A 2017 meta-analysis found that the odds of autoimmune thyroiditis were more than three times higher in women with PCOS compared with controls. Worsening hypothyroidism in a woman with PCOS can amplify insulin resistance, worsen menstrual irregularity, and increase cardiovascular risk. Adding an interacting supplement to an already-complicated hormonal picture compounds the problem.

Perimenopause and Menopause

This is the life stage where the Armour Thyroid plus St. John's Wort combination is most likely to occur. Perimenopause brings mood instability, sleep disruption, and depressive symptoms that drive many women to try St. John's Wort. It also brings escalating rates of new-onset hypothyroidism. Estrogen fluctuations change thyroid-binding globulin (TBG) levels, which alters the bound-to-free ratio of T4. A woman who was adequately replaced on Armour Thyroid before perimenopause may find her needs shifting anyway, and adding an enzyme inducer on top of that hormonal volatility makes titration significantly harder.

The WomanRx clinical framework for perimenopausal women on thyroid hormone replacement: any new supplement with CYP3A4 inducing potential should trigger a TSH recheck at six weeks, not at the annual review. Waiting a full year to discover that TSH has risen to 8 mIU/L while a woman is attributing her fatigue to menopause means months of unnecessary symptoms and potential cardiovascular strain.

Postpartum Thyroiditis

Postpartum thyroiditis affects roughly 5 to 10% of women in the year after delivery, and some of these women end up on permanent thyroid hormone replacement. A postpartum woman reaching for St. John's Wort for mood support alongside a new Armour Thyroid prescription is at particular risk for this interaction being missed, because postpartum mood and thyroid symptoms overlap substantially and both are often under-addressed.

Pregnancy and Lactation: Critical Safety Information

Armour Thyroid in pregnancy: Thyroid hormone replacement is not only permitted in pregnancy, it is mandatory for women with hypothyroidism. Untreated or undertreated hypothyroidism in pregnancy is associated with impaired fetal neurodevelopment, preterm birth, and placental abruption. Thyroid hormone requirements increase by approximately 25 to 50% in the first trimester. Women on Armour Thyroid should have TSH checked as soon as pregnancy is confirmed and every four weeks through 20 weeks of gestation. The target TSH in pregnancy is generally below 2.5 mIU/L in the first trimester.

St. John's Wort in pregnancy: St. John's Wort is not recommended during pregnancy. Human data are limited, but animal studies have raised concerns about uterine contractility, and a 2018 systematic review found insufficient safety evidence to recommend its use in pregnant women. The combination of a supplement with unknown fetal safety and one that may reduce the effectiveness of a medication critical to fetal brain development is doubly problematic.

Lactation: Small amounts of hypericin from St. John's Wort pass into breast milk. A study of five nursing women found measurable hypericin in milk samples, though levels were low and no adverse infant effects were documented in that small group. The evidence base is too thin to establish safety, and most lactation consultants and pharmacists advise against use. Armour Thyroid, by contrast, is considered compatible with breastfeeding; small amounts of thyroid hormone are naturally present in breast milk and the additional amount from replacement doses is not clinically concerning.

Contraception note: St. John's Wort is a well-documented reducer of oral contraceptive efficacy through CYP3A4 and P-glycoprotein induction. The FDA and the European Medicines Agency have both issued warnings that St. John's Wort can reduce plasma concentrations of ethinyl estradiol and progestin, increasing the risk of breakthrough bleeding and unintended pregnancy. If you are using hormonal contraception alongside Armour Thyroid and you add St. John's Wort, you are simultaneously risking thyroid hormone under-replacement and contraceptive failure. Use a barrier method or an intrauterine device if you choose to continue St. John's Wort.

Who This Combination Is Not Right For

The combination of St. John's Wort and Armour Thyroid carries the most risk in these groups:

• Women trying to conceive or currently pregnant
• Women with PCOS and coexisting thyroid disease
• Perimenopausal women already navigating TBG shifts from estrogen fluctuation
• Women on hormonal contraception (triple interaction risk)
• Anyone whose TSH is already at the upper end of the therapeutic range before starting the supplement
• Women with a history of postpartum thyroiditis or positive thyroid antibodies (TPO-Ab), where thyroid reserve is already limited

Who Might Use Both With Careful Monitoring

There is no absolute contraindication that means St. John's Wort will catastrophically harm every woman on Armour Thyroid. A woman who has tried and found conventional antidepressants intolerable, whose TSH is comfortably in range, who is not pregnant or trying to conceive, and who is willing to have TSH rechecked at six weeks after starting St. John's Wort could potentially use both. She would need to understand:

• Her Armour Thyroid dose may need to increase.
• Stopping St. John's Wort later without re-adjusting thyroid hormone could cause over-replacement.
• Regular TSH and free T4 monitoring is not optional.
• This is not a combination most thyroid specialists or integrative practitioners would endorse as first-line.

Safer alternatives for mood support during thyroid disease include omega-3 fatty acids, structured cognitive behavioral therapy, and, if antidepressants are appropriate, SSRIs that do not have the same enzyme-inducing profile. A 2021 Cochrane review confirmed that St. John's Wort performs better than placebo for mild-to-moderate depression and similarly to standard antidepressants, so there is real reason women reach for it. That does not make it low-risk in this combination.

What to Do If You Are Already Taking Both

1. Do not stop either abruptly without speaking to your prescribing clinician.
2. Get a TSH and free T4 drawn as soon as possible if you haven't had one in the past six weeks.
3. Tell your prescriber you are taking St. John's Wort. Herb-drug interactions are underreported partly because patients don't mention supplements and clinicians don't ask.
4. If your TSH has risen, your Armour Thyroid dose will likely need to be increased, or St. John's Wort will need to be discontinued.
5. If you decide to stop St. John's Wort, plan a TSH recheck four to six weeks after stopping, especially if your dose was adjusted upward during co-use.
6. If you are in perimenopause and using St. John's Wort for hot flashes or mood, discuss whether menopausal hormone therapy or a different pharmacologic approach might address the root cause more reliably and without the thyroid interaction.

Monitoring Schedule: A Practical Guide

| Situation | When to Recheck TSH | |---|---| | Starting St. John's Wort on existing Armour Thyroid | 4-6 weeks after starting | | Stopping St. John's Wort after co-use | 4-6 weeks after stopping | | Dose adjustment made during co-use | 6-8 weeks after adjustment | | Pregnancy confirmed while taking both | Immediately; recheck every 4 weeks to 20 weeks | | Perimenopausal with estrogen fluctuation added | Every 3-4 months minimum |

A Note on Evidence Quality and the Women's Health Gap

The direct human evidence base for St. John's Wort interactions with thyroid hormone replacement is genuinely sparse. The interaction is inferred from well-established CYP3A4 pharmacology, from case reports, and from analogy with documented St. John's Wort interactions with other drugs. Women were systematically excluded from early pharmacokinetic trials through much of the 20th century, and drug-supplement interaction research has historically been even less rigorous about including female participants or stratifying data by menstrual cycle phase, hormonal contraceptive use, or menopausal status. This means that the actual magnitude of the Armour Thyroid plus St. John's Wort interaction in women across different hormonal life stages is genuinely unknown. The clinical recommendation to avoid the combination, or to monitor closely when it cannot be avoided, is reasonable and conservative given that gap. It is not overcaution for its own sake.